← SynDRA
MEROPENEM
SynDRA canonical compound SYN0001232 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Mechanism of action | bacterial cell wall synthesis inhibitor |
| Indication | intra-abdominal infections | meningitis | skin infections |
| Disease area | infectious disease |
All known targets
- bla OXA-48
- blaNDM-1
- blaVIM-2
- dacA
- dacB
- dacC
- pbpA
- ponA
- ska
Mechanisms of action (all sources)
- bacterial cell wall synthesis inhibitor
- dacB INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ACHE
- ERBB2
- MMP1
- MC5R
- MC4R
- MC3R
- MAPK3
- MAPK14
- MAPK1
- MAOA
- LCK
- KCNH2
- HTR6
- HTR2C
- HTR2B
- HTR2A
- HRH2
- HRH1
- HMGCR
- HDAC6
- FYN
- FLT1
- ESR2
- MMP9
- NPY1R
- NPY2R
- PTPRC
- TBXAS1
- TBXA2R
- TACR2
- TACR1
- SLC6A4
- SLC6A3
- SLC6A2
- SIGMAR1
- SAMHD1
- PTGS2
- NR1I2
- PTGS1
- PTAFR
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anti-Bacterial Agents
- Anti-Infective Agents
ATC classes
- J01D · OTHER BETA-LACTAM ANTIBACTERIALS
Cross-references
Synonyms
- MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
- MERREM IV
- VABOMERE
- Vabomere
- meropenem hydrate
- merrem
- meropenem trihydrate
- Meropenem hydrate
- Meropenem trihydrate
- Meronem
- Meropenem (as trihydrate)
- Meropenem anhydrous
- Meropenem, anhydrous
- Merrem i.v.
- ICI 194,660
- ICI-194660
- NSC-759621
- SM-7338
- Meropenem component of vabomere
- Merrem
- MEPM
- MERONEM
- Meropen
- Mepem (TN)
- Meronem (TN)
- Meropen (TN)
- Meropenem (INN)
- Merrem (TN)
- Neopenem (TN)
- Merrem I.V. (TN)
- meropenem trihydrate (ep monograph)
- Meropenem Trihydrate
- ICI 194660
- FV9J3JU8B1
- meropenem (usp-rs)
- meropenem (usp impurity)
- Meropenem Hydrate
Reported adverse events
- Nausea
- Phlebitis
- Hypersensitivity
- Pain
- Rash
- Seizure
- Thrombocytopenia
- Vomiting
- Glossitis
- Injection site reaction
- Stevens-Johnson syndrome
- Death
Look up MEROPENEM in the interactive SynDRA portal →